Uehara, T., Yoshida, H., & Kato, T. (2020). Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy. Gynecol Oncol Rep.
Chicago-tyylinen lähdeviittausUehara, Takashi, Hiroshi Yoshida, ja Tomoyasu Kato. "Pelvic Seromucinous Borderline Tumor 26 years After Ovarian Seromucinous Borderline Tumor Managed With Post-treatment Estrogen Replacement Therapy." Gynecol Oncol Rep 2020.
MLA-viiteUehara, Takashi, Hiroshi Yoshida, ja Tomoyasu Kato. "Pelvic Seromucinous Borderline Tumor 26 years After Ovarian Seromucinous Borderline Tumor Managed With Post-treatment Estrogen Replacement Therapy." Gynecol Oncol Rep 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.